# CORRESP — XORTX Therapeutics Inc.  (XRTX)  (CIK 0001729214)

> <strong>XORTX Therapeutics Inc.  (XRTX)  (CIK 0001729214) → SEC staff</strong> · filed 2026-02-12 · ticker XRTX · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001104659-26-014490
- **Form:** CORRESP
- **Filer:** XORTX Therapeutics Inc.  (XRTX)  (CIK 0001729214)
- **CIK:** 0001729214
- **Ticker:** XRTX
- **Filed:** 2026-02-12
- **SIC industry:** 2834
- **HQ:** Vancouver, A1

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1729214/000110465926014490/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1729214&type=UPLOAD&dateb=&owner=include&count=40

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, XORTX Therapeutics Inc.  (XRTX)  (CIK 0001729214) (CIK 0001729214), filed 2026-02-12, accession 0001104659-26-014490. Retrieved via MORVS 2026-11-04 from https://api.morvs.ai/comment-letter/0001104659-26-014490.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*